Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Companies
Recent news which mentions Companies
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
30
31
Next >
Elon Musk says Tesla will hold a shareholder vote to incorporate in Texas after Delaware pay snub
February 01, 2024
Tags
Millionaires and Billionaires
Transportation
Environment
From
CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
January 31, 2024
Tags
Social issues
Business News
Business
From
CNBC.com News
GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost
January 31, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Health & Science
From
CNBC.com News
Vertex non-opioid painkiller shows positive results in critical late-stage trial on acute pain
January 30, 2024
Tags
CRISPR Therapeutics AG
US: News
Pharmaceuticals
From
CNBC.com News
Pfizer beats earnings estimates as declining Covid business performs better than expected
January 30, 2024
Tags
Business News
Earnings
US: News
From
CNBC.com News
Saudi Arabia's Aramco halts plans to increase maximum crude production capacity
January 30, 2024
Tickers
OIL
Tags
Oil
Energy
Breaking News: Markets
From
CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
January 28, 2024
Tags
Health care industry
Moderna Inc
Health & Science
From
CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
January 26, 2024
Tags
Business News
Companies
Business
From
CNBC.com News
Humana stock plunges on dismal 2024 forecast, as insurers face soaring medical costs
January 25, 2024
Tags
Biotechnology
Health & Science
Elevance Health Inc
From
CNBC.com News
Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million
January 23, 2024
Tags
Companies
Business
Business News
From
CNBC.com News
Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump
January 23, 2024
Tags
Companies
Business
US: News
From
CNBC.com News
Gilead stock falls after disappointing lung cancer study results
January 22, 2024
Tags
Breaking news
Biotech and Pharmaceuticals
Pharmaceuticals
From
CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
January 17, 2024
Tags
Bayer AG
Health care industry
Pfizer Inc
From
CNBC.com News
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
January 14, 2024
Tags
Business News
JPMORGAN DRN
Business
From
CNBC.com News
CVS to close 'select' pharmacies in Target stores in the coming months
January 11, 2024
Tags
Business News
Business
Companies
From
CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
January 08, 2024
Tags
Merck & Co Inc
Abbvie Inc
US: News
From
CNBC.com News
Moderna Covid vaccine sales plunge by two-thirds in 2023, but meet company's $6 billion forecast
January 08, 2024
Tags
Business News
US: News
Companies
From
CNBC.com News
Eli Lilly's direct drug sales may not upend the industry alone – but others could follow suit
January 05, 2024
Tags
Companies
Business
Business News
From
CNBC.com News
Florida wins first FDA approval to import cheaper drugs from Canada
January 05, 2024
Tags
Biotech and Pharmaceuticals
Pharmaceuticals
Breaking News: Politics
From
CNBC.com News
It's an 'amazing time' to be a woman in business. Female founders say the entrepreneurial landscape is changing
January 04, 2024
Tags
Investment management
Companies
Discrimination
From
CNBC.com News
Walgreens posts earnings beat but slashes quarterly dividend nearly in half
January 04, 2024
Tags
Earnings
Business News
Companies
From
CNBC.com News
Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years
January 02, 2024
Tags
Merck & Co Inc
US: News
Pharmaceuticals
From
CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
December 28, 2023
Tags
US: News
AstraZeneca PLC
Merck & Co Inc
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
US: News
Biotech and Pharmaceuticals
Amgen Inc
From
CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
Tags
Pfizer Inc
Health care industry
Health & Science
From
CNBC.com News
Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says
December 14, 2023
Tags
Science
Health care industry
Moderna Inc
From
CNBC.com News
Vertex shares pop after non-opioid painkiller posts positive mid-stage trial results
December 13, 2023
Tags
US: News
CRISPR Therapeutics AG
Biotech and Pharmaceuticals
From
CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
December 11, 2023
Tags
Companies
Business
Business News
From
CNBC.com News
Cigna shares jump on reports of abandoned Humana buyout, plans for $10 billion stock buyback
December 11, 2023
Tags
Biotechnology
Health & Science
Mergers
From
CNBC.com News
Biden administration asserts power to seize drug patents in move to slash high prices
December 07, 2023
Tags
US: News
Policy
Biotech and Pharmaceuticals
From
CNBC.com News
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
30
31
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.